As a prognosticator, elevated bFGF concentrations were detected in samples of bladder cancer patients compared to controls, suggesting that this growth factor could be a reliable marker in the risk stratifications of bladder cancer patients [170]. The gene discussed is FGF2; the disease is urinary bladder cancer.